Csenge Advisory Group’s Cross Country Healthcare CCRN Stock Holding History

Csenge Advisory Group’s Portfolio CCRN Stock Details CCRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,502	Closed	-$234K	–	665
2023 Q1	$234K	Buy	10,502 +551	+6%	+$14.4K	0.02%	515
2022 Q4	$264K	Buy	+9,951	New	+$325K	0.02%	495
2018 Q4	–	Sell	-13	Closed	–	–	404
2018 Q3	$0	Buy	+13	New	+$133	﹤0.01%	1105

Other funds holding CCRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

SCM

Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Csenge Advisory Group's CCRN Position: Q2 2023 in Review

Csenge Advisory Group sold out of Cross Country Healthcare (CCRN) in Q2 2023, closing a stake of 10,502 shares — an estimated $234K sold.

Csenge Advisory Group first reported a position in CCRN in Q3 2018 and held it in 3 quarters. The position peaked at $264K in Q4 2022. 194 funds tracked by Wall St. Rank hold CCRN as of Q2 2023.

Csenge Advisory Group reported no remaining Cross Country Healthcare position as of Q2 2023 after selling out during the quarter.
Csenge Advisory Group sold 10,502 Cross Country Healthcare shares in Q2 2023, an estimated $234K.
Csenge Advisory Group first reported a position in Cross Country Healthcare in Q3 2018 and held it in 3 quarters.
Csenge Advisory Group's Cross Country Healthcare position peaked at $264K in Q4 2022.
194 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2023.

Based on Csenge Advisory Group's 13F filing for Q2 2023, filed 20 Jul 2023.